SCHEMBL17835532

SCHEMBL17835532

O=C1OC(O[PH](=O)O)c2ccccc21

nearest known ligand 0.43

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
HSD17B10 Q99714 3/20 0.38
KDM4E B2RXH2 3/20 0.38
POLB P06746 1/20 0.35
LMNA P02545 3/20 0.35
MEN1 O00255 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
MAPT P10636 1/20 0.34
CYP2C9 P11712 1/20 0.34
HPGD P15428 1/20 0.34
CYP2C19 P33261 1/20 0.34
KMT2A Q03164 1/20 0.34
RECQL P46063 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10238639 0.86 ALDH1A1 (0.46) ALDH1A1HSD17B10KDM4EPOLBMAPT
SCHEMBL14180631 0.83 ALDH1A1 (0.43) ALDH1A1HSD17B10KDM4EPOLBLMNA
SCHEMBL17427515 0.79 ALDH1A1 (0.40) ALDH1A1HSD17B10KDM4EPOLBLMNA
SCHEMBL29441612 0.77 ALDH1A1 (0.52) ALDH1A1HSD17B10KDM4EPOLBMEN1
SCHEMBL11213802 0.77 ALDH1A1 (0.52) ALDH1A1HSD17B10KDM4EPOLBMEN1
SCHEMBL29122850 0.75 ALDH1A1 (0.43) ALDH1A1HSD17B10KDM4ELMNAMEN1
SCHEMBL2631833 0.74 ALDH1A1 (0.48) ALDH1A1HSD17B10KDM4EPOLBLMNA
SCHEMBL21268024 0.74 ALDH1A1 (0.44) ALDH1A1HSD17B10KDM4EPOLBLMNA
SCHEMBL14950486 0.72 POLB (0.56) ALDH1A1HSD17B10KDM4EPOLBLMNA
SCHEMBL10310217 0.72 POLB (0.56) ALDH1A1HSD17B10KDM4EPOLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2824098-B1 Method for the preparation of 4-[3-(4-cyclopropanecarbonyl- piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one KUDOS PHARM LTD (GB) 2016-06-22 EP claimed
WO-2025065057-A1 METHODS OF MINIMISING EFFECTS OF RADIATION EXPOSURE THE UNIVERSITY OF ADELAIDE (AU) 2025-04-03 WO disclosed
CN-118359545-A Preparation method of Olaparib monohydrate 杭州中美华东制药有限公司 2024-07-19 CN disclosed
CN-116143700-B Phthalazinone compound, and preparation method and application thereof 沈阳药科大学 2024-06-28 CN disclosed
EP-4384501-A1 PROCESS FOR THE PREPARATION OF OLAPARIB, AND CRYSTALLINE FORM THEREOF Glenmark Life Sciences Limited (IN) 2024-06-19 EP disclosed
CN-117355303-A Compounds and their use for the treatment of neurodegenerative, degenerative and metabolic disorders 佛罗里达大学研究基金会公司 2024-01-05 CN disclosed
CN-117186045-A Isobenzofuran-1 (3H) -ketone TREK-1 inhibitor, preparation method, pharmaceutical composition and application thereof 中国医学科学院药物研究所 2023-12-08 CN disclosed
CN-116535397-A Isobenzofuran-1 (3H) -one compound, preparation method, pharmaceutical composition and application thereof 中国医学科学院药物研究所 2023-08-04 CN disclosed
CN-116143700-A Phthalazinone compound, and preparation method and application thereof 沈阳药科大学 2023-05-23 CN disclosed
WO-2023017393-A1 PROCESS FOR THE PREPARATION OF OLAPARIB, AND CRYSTALLINE FORM THEREOF GLENMARK LIFE SCIENCES LIMITED (IN) 2023-02-16 WO disclosed
CN-106817899-B Spiroheptane as ROCK inhibitor 百时美施贵宝公司 2021-03-09 CN disclosed